TherapeuticsMD
TXMD
TXMD
41 hedge funds and large institutions have $11.7M invested in TherapeuticsMD in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $19.4M → $11.7M (-$7.75M)
Holders
41
Holding in Top 10
–
Calls
$517K
Puts
$296K
Top Buyers
| 1 | +$695K | |
| 2 | +$467K | |
| 3 | +$144K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.6K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$30.2K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$463K | |
| 3 | -$224K | |
| 4 |
Millennium Management
New York
|
-$111K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$58.6K |